Ключевые слова:
tizimli sklerodermiya, TGF-β, prokollagen I, IL-6, TNFα, sitokin profili, fibroz, prognostik belgilovchilar.Библиографические ссылки
1. Buranova SN, Akhmedov KhS, Razakova FS. The Importance of Treatment Aimed at the Dynamics of Cartilage Oligo- mer Matrix Protein (COMP) in Patients with the Knee Joint Os- teoarthritis. Amer J Med Med Sci.2021;11(2):148-53.
2. Buranova SN, Akhmedov KhS, Razakova FS. Cartilage oligomeric matrix protein (COMP) in early diagnosis of osteoar- thritis. Chin J Occup Dis Labor and Health.2021.39(7):93-100.
3. Gabrielli A, Avvedimento EV, Krieg T. Scleroderma: from pathogenesis to therapy. Nat Rev Rheumatol.2019;15:1-18.
4. Khalmetova FI, Akhmedov XS, Alibekova GA. Features of the course of the joint syndrome in various forms of reactive arthritis. Galaxy Int Interdisciplinary Res J.2023;11(4):832-7.
5. Kowal-Bielecka O, Fransen J, Avouac J et al. Update of EU- LAR recommendations for the treatment of systemic sclerosis. Ann Rheum Dis.2017;76:1327-39.
6. Rakhimova M et al. Endothelin-1biomarker Features In Patients With Ankylosing Spondylitis After COVID-19. J posi- tive school Рsychol.2022;6.
7. Rakhimova MB. Impared endothelial dysfunction in covid-19: an overview of evidence, biomarkers in patients with ankylosing spondylitis. Int Multidisciplinary Res Acad Sci.2023;6(7):20-27.
8. Svegliati S, Bellando-Randone S, Matucci-Cerinic M. In- terleukin-6 in systemic sclerosis: pathogenic role and thera- peutic implications. Clin Rev Allergy Immunol.2023;64:15-28.
9. Tashkin DP, Elashoff R, Clements PJ et al. Effects of cyclo- phosphamide on systemic sclerosis–related interstitial lung disease: long-term follow-up of the Scleroderma Lung Study. Ann. Rheum. Dis.2019;78:625-32.
Ying W, Marangoni RG, Fang F et al. Role of TGF-β and pro- fibrotic pathways in systemic sclerosis. J Clin Med.2020;9:2345.
